Literature DB >> 28067347

Fc microparticles can modulate the physical extent and magnitude of complement activity.

Brandon Alexander Holt1, Michael C Bellavia1, Daniel Potter2, David White3, Sean R Stowell4, Todd Sulchek5.   

Abstract

The complement system is an integral component of the humoral immune system, and describes a cascade of interacting proteins responsible for the opsonization and lysis of foreign pathogens, in addition to the recruitment of immune cells. However, complement activation is also implicated in the progression and complication of immune dysfunctions such as sepsis. Microparticle (MP) biomaterials capable of tuning the local magnitude of serum complement activation could improve complement-mediated cytotoxicity to serum-resistant bacteria or calm an overactive immune response during sepsis. We demonstrate that model Fc-functionalized microparticles can be designed to either enhance or diminish the local cytotoxic effect of complement activation in human serum. The particles were formed with either the antibody Fc domains oriented outward from the particle surface or randomly adsorbed in a non-oriented fashion. In the oriented Fc form, complement products were directly sequestered to the particle surface, including C5a, a potent anaphylatoxin that, when elevated, is associated with poor sepsis prognosis. The oriented particle also lowered the cytotoxicity of serum and thus decreased the antibiotic effect when compared to serum alone. Conversely, the non-oriented microparticles were found to sequester similar levels of C5a, but much lower levels of iC3b and TCC on the microparticle surface, thereby increasing the amount of the soluble terminal complement complex. In addition, the non-oriented microparticles extend the distance over which TCC forms and enhance serum cytotoxicity to bacteria. Together, these two types of complement-modulating particles provide the first biomaterial that can functionally modify the range of complement activation at sites distant from the particle surface. Thus, biomaterials that exploit Fc presentation provide new possibilities to functionally modulate complement activation to achieve a desired clinical result.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067347      PMCID: PMC5330945          DOI: 10.1039/c6bm00608f

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  63 in total

Review 1.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

2.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

3.  Role of particle size in phagocytosis of polymeric microspheres.

Authors:  Julie A Champion; Amanda Walker; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-03-29       Impact factor: 4.200

Review 4.  Blurred line between chemotactic chase and phagocytic consumption: an immunophysical single-cell perspective.

Authors:  Volkmar Heinrich; Cheng-Yuk Lee
Journal:  J Cell Sci       Date:  2011-09-15       Impact factor: 5.285

5.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.

Authors:  Paul Gallo; Ricardo Gonçalves; David M Mosser
Journal:  Immunol Lett       Date:  2010-07-27       Impact factor: 3.685

7.  Bifunctional Janus microparticles with spatially segregated proteins.

Authors:  Jennifer L Tang; Kipp Schoenwald; Daniel Potter; David White; Todd Sulchek
Journal:  Langmuir       Date:  2012-06-18       Impact factor: 3.882

8.  C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies.

Authors:  R Gennaro; T Simonic; A Negri; C Mottola; C Secchi; S Ronchi; D Romeo
Journal:  Eur J Biochem       Date:  1986-02-17

9.  TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Authors:  Patricia M Pacheco; Benjamin LE; David White; Todd Sulchek
Journal:  Nano Life       Date:  2013-06

Review 10.  Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

Authors:  Janos Szebeni; Franco Muggia; Alberto Gabizon; Yechezkel Barenholz
Journal:  Adv Drug Deliv Rev       Date:  2011-07-14       Impact factor: 15.470

View more
  5 in total

1.  Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.

Authors:  Brandon Alexander Holt; Quoc D Mac; Gabriel A Kwong
Journal:  J Vis Exp       Date:  2018-07-16       Impact factor: 1.355

Review 2.  Pathogenesis of Drug Induced Non-Allergic Angioedema: A Review of Unusual Etiologies.

Authors:  Junior Kalambay; Haider Ghazanfar; Karen A Martes Pena; Ruhul A Munshi; George Zhang; Jay Y Patel
Journal:  Cureus       Date:  2017-08-23

3.  Deconvolving multiplexed protease signatures with substrate reduction and activity clustering.

Authors:  Qinwei Zhuang; Brandon Alexander Holt; Gabriel A Kwong; Peng Qiu
Journal:  PLoS Comput Biol       Date:  2019-09-03       Impact factor: 4.475

4.  Dimensionless parameter predicts bacterial prodrug success.

Authors:  Brandon Alexander Holt; McKenzie Tuttle; Yilin Xu; Melanie Su; Joachim J Røise; Xioajian Wang; Niren Murthy; Gabriel A Kwong
Journal:  Mol Syst Biol       Date:  2022-01       Impact factor: 11.429

5.  Protease circuits for processing biological information.

Authors:  Brandon Alexander Holt; Gabriel A Kwong
Journal:  Nat Commun       Date:  2020-10-06       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.